Harpoon Therapeutics, Inc. announced the appointment of James Bucher, J.D. as Chief Legal Officer, and the promotion of Wendy Chang, to Chief People Officer. Mr. Bucher and Ms. Chang are part of the executive management team and report directly to the Chief Executive Officer. Mr. Bucher is a proven leader with over thirty years of legal expertise, including over ten years dedicated to senior roles in life science companies.

Most recently, he served as Executive Vice President, General Counsel, and Head of Human Resources at Eliem Therapeutics. Mr. Bucher also served as Executive Vice President and General Counsel for Alder Biopharmaceuticals, held a senior legal position at Exelixis, consulted life sciences companies, and was a partner at Shearman & Sterling LLP. In his current role at Harpoon, Mr. Bucher is tasked with leading all legal aspects of the organization, including corporate governance, intellectual property, and compliance functions.

Mr. Bucher received his J.D. with distinction from Emory University School of Law and his B.A. from Colgate University. Ms. Chang joined Harpoon in 2022 as Senior Vice President of Human Resources, bringing more than twenty years of human resources experience in life sciences. Ms. Chang?s promotion to the role of Chief People Officer demonstrates her valuable contributions to the Company during her tenure, along with the organization's commitment to its employees, corporate culture, and the future growth and development of its team.

Ms. Chang has an extensive background in aligning talent with organizations? overall vision and direction. Before joining Harpoon, she was Head of People and Culture at IDbyDNA; before that, she served as Vice President, Human Resources at Gilead Sciences.

Ms. Chang?earned a B.S. in accounting and business/management from the University of California, Riverside, and completed the Global Fellow of Talent Management program at The Wharton School of the University of Pennsylvania.